• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Peltz's Trian Reportedly Builds Stake In 3M Spinoff Solventum

    7/22/24 4:29:04 PM ET
    $MMM
    $SOLV
    Medical/Dental Instruments
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email

    - Bloomberg

    Get the next $MMM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MMM
    $SOLV

    CompanyDatePrice TargetRatingAnalyst
    Solventum Corporation
    $SOLV
    1/26/2026$97.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Solventum Corporation
    $SOLV
    1/20/2026$100.00Neutral → Outperform
    Mizuho
    3M Company
    $MMM
    1/16/2026$182.00Overweight → Neutral
    Analyst
    3M Company
    $MMM
    12/8/2025$178.00Buy → Hold
    Deutsche Bank
    Solventum Corporation
    $SOLV
    12/2/2025$100.00Neutral → Buy
    BTIG Research
    3M Company
    $MMM
    10/22/2025$160.00Underweight → Equal-Weight
    Morgan Stanley
    Solventum Corporation
    $SOLV
    10/1/2025$77.00Neutral
    UBS
    Solventum Corporation
    $SOLV
    9/11/2025$80.00Hold
    Jefferies
    More analyst ratings

    $MMM
    $SOLV
    SEC Filings

    View All

    3M Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - 3M CO (0000066740) (Filer)

    2/5/26 8:32:39 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form S-3ASR filed by 3M Company

    S-3ASR - 3M CO (0000066740) (Filer)

    2/3/26 4:50:35 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form IRANNOTICE filed by 3M Company

    IRANNOTICE - 3M CO (0000066740) (Filer)

    2/3/26 4:15:06 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    $SOLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Solventum upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Solventum from Sector Weight to Overweight and set a new price target of $97.00

    1/26/26 8:32:07 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Solventum upgraded by Mizuho with a new price target

    Mizuho upgraded Solventum from Neutral to Outperform and set a new price target of $100.00

    1/20/26 8:47:32 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    3M downgraded by Analyst with a new price target

    Analyst downgraded 3M from Overweight to Neutral and set a new price target of $182.00

    1/16/26 8:27:24 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    $SOLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: EVP & Chief HR Officer Dickson Zoe L exercised 20,519 shares at a strike of $142.94 and sold $3,487,614 worth of shares (20,519 units at $169.97) (SEC Form 4)

    4/A - 3M CO (0000066740) (Issuer)

    2/10/26 4:40:16 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    EVP & Chief HR Officer Dickson Zoe L exercised 25,055 shares at a strike of $102.89 and sold $4,267,869 worth of shares (25,055 units at $170.34) (SEC Form 4)

    4 - 3M CO (0000066740) (Issuer)

    2/10/26 4:22:21 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by EVP Chief Strategy Officer Van Wyck Jonathan G.

    4 - 3M CO (0000066740) (Issuer)

    2/10/26 4:12:53 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    $SOLV
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

    For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

    1/22/21 3:54:10 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    $SOLV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    3M Announces New Board Appointment

    Neil Mitchill elected to the Board of Directors ST. PAUL, Minn., Feb. 5, 2026 /PRNewswire/ -- 3M (NYSE:MMM) announced today the election of Neil G. Mitchill, Jr. to 3M's Board of Directors, effective Feb. 6, 2026. Mr. Mitchill also has been appointed as a member of the Audit Committee and the Nominating and Governance Committee of the Board. Mr. Mitchill is the Executive Vice President and Chief Financial Officer, RTX Corporation. Holding this position since 2021, his responsibilities span financial reporting and controls, planning and analysis, investor relations, internal audit, tax and treasury. Prior to his current role, Mr. Mitchill served as Corporate Vice President of Financial Planni

    2/5/26 8:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Board Declares Quarterly Dividend

    ST. PAUL, Minn., Feb. 3, 2026 /PRNewswire/ -- The 3M Company Board of Directors (NYSE:MMM) today declared a dividend on the company's common stock of $0.78 per share for the first quarter of 2026. The dividend is payable March 12, 2026, to shareholders of record at the close of business on Feb. 13, 2026. 3M has paid dividends to its shareholders without interruption for more than 100 years. About 3M 3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global foo

    2/3/26 4:10:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026

    ST. PAUL, Minn., Feb. 3, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) will release its fourth quarter fiscal 2025 financial results on Thursday, Feb. 26, 2026, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results and fiscal year 2026 outlook. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Thursday, Feb. 26, 2026 Time: 3:30 p.m. CST / 4:30 p.m. EST Location: https://investors.solventum.com U.S. dial-in +1 (800) 715-9871 Internation

    2/3/26 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $MMM
    $SOLV
    Financials

    Live finance-specific insights

    View All

    3M Board Declares Quarterly Dividend

    ST. PAUL, Minn., Feb. 3, 2026 /PRNewswire/ -- The 3M Company Board of Directors (NYSE:MMM) today declared a dividend on the company's common stock of $0.78 per share for the first quarter of 2026. The dividend is payable March 12, 2026, to shareholders of record at the close of business on Feb. 13, 2026. 3M has paid dividends to its shareholders without interruption for more than 100 years. About 3M 3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global foo

    2/3/26 4:10:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026

    ST. PAUL, Minn., Feb. 3, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) will release its fourth quarter fiscal 2025 financial results on Thursday, Feb. 26, 2026, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results and fiscal year 2026 outlook. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Thursday, Feb. 26, 2026 Time: 3:30 p.m. CST / 4:30 p.m. EST Location: https://investors.solventum.com U.S. dial-in +1 (800) 715-9871 Internation

    2/3/26 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    3M Reports Fourth-Quarter and Full-Year 2025 Results; Initiates Full-Year 2026 Financial Guidance

    Q4 GAAP sales of $6.1 billion, up 2.1%; operating margin of 13.0%, down 510 bps; EPS of $1.07, down 20%, all YoYAdjusted sales of $6.0 billion with organic growth of 2.2% YoYAdjusted operating margin of 21.1%, up 140 bps YoYAdjusted EPS of $1.83, up 9% YoYQ4 operating cash flow of $1.6 billion with adjusted free cash flow of $1.3 billionFull-year GAAP sales of $24.9 billion, up 1.5%; operating margin of 18.6%, down 100 bps; EPS of $6.00, down 17%, all YoYAdjusted sales of $24.3 billion with organic growth of 2.1% YoYAdjusted operating margin of 23.4%, up 200 bps YoYAdjusted EPS of $8.06, up 10% YoYFull-year operating cash flow of $2.3 billion with adjusted free cash flow of $4.4 billionST. P

    1/20/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    $SOLV
    Leadership Updates

    Live Leadership Updates

    View All

    Lanvin Group Announces Appointment of New Chief Financial Officer

    SHANGHAI, Oct. 24, 2025 /PRNewswire/ -- Lanvin Group (NYSE:LANV), a global luxury fashion group, today announced the appointment of Mr. Jiyang Han as Chief Financial Officer (CFO) of the Company, effective November 1, 2025. In this role, Mr. Han will oversee the Group's financial affairs, including financial planning and analysis, accounting and controllership, financial management, treasury, investment and financing projects, and investor relations.  Mr. Han brings nearly two decades of experience in corporate finance, investment banking, and global business management. He has served as Co-CIO and Assistant President of Yuyuan (SHSE: 600655) since June 2025. Prior to that, he was the M&A a

    10/24/25 6:00:00 AM ET
    $LANV
    $MMM
    Apparel
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Solventum Appoints Heather Knight as Chief Commercial Officer

    ST. PAUL, Minn., Oct. 21, 2025 /PRNewswire/ -- Solventum (NYSE:SOLV) announced today the appointment of Heather Knight as Chief Commercial Officer, effective November 10, 2025. In this newly created role, Ms. Knight will oversee global commercial and R&D operations across Solventum's MedSurg, Dental Solutions and Health Information Systems segments, and will report directly to CEO Bryan Hanson. Ms. Knight brings over 30 years of leadership experience in the MedTech industry. Most recently, she served as Chief Operating Officer at Baxter International, where she led global sale

    10/21/25 5:00:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    3M Annual Meeting Results

    ST. PAUL, Minn., May 13, 2025 /PRNewswire/ -- At today's Annual Meeting of Shareholders, 3M (NYSE:MMM) shareholders overwhelmingly supported each of the proposals recommended for approval by the company. Preliminary Shareholder Voting Results 3M shareholders today voted on the following business items: 1) Shareholders supported 11 directors for one-year terms to expire at the company's 2026 Annual Meeting: David P. Bozeman, President, Chief Executive Officer and Director, C.H. Robinson Worldwide, Inc.Thomas "Tony" K. Brown, retired Group Vice President, Global Purchasing, Ford

    5/13/25 4:30:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    $SOLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Solventum Corporation

    SC 13G/A - Solventum Corp (0001964738) (Subject)

    11/12/24 5:47:11 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Solventum Corporation

    SC 13G/A - Solventum Corp (0001964738) (Subject)

    11/4/24 1:47:43 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/13/24 4:56:03 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care